Ocrelizumab

[product name] ocreves

[English common name] ocrelizumab

[Chinese common name]

[English name]

[Chinese other name]

[Indications] Ocrevus is a treatmentMultiple sclerosisThe drug – Multiple Sclerosis is a neurological inflammatory disease that can cause symptoms such as weakness, difficulty walking and vision problems.
Ocrevus is used in two groups of patients: adults with relapsing multiple sclerosis (RMS) who have a sudden onset (relapse) and then have a mild or asymptomatic period; with primary progressive multiple sclerosis (PPMS) Adults, as time goes on, the symptoms will gradually deteriorate.
Ocrevus contains the active substance ocrelizumab.

[Usage and Dosage] Ofcrevus enters the vein as an infusion (drop). The first two infusions were separated for two weeks and then infused every six months. Other medications (corticosteroids and antihistamines) are given to patients prior to each infusion to help prevent potentially dangerous reactions. If a reaction occurs during the infusion, a slower response can be stopped or given. Patients should be monitored during the infusion process and monitored at least one hour thereafter, and facilities that manage severe reactions should be readily available.

[Storage]

[Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.